CA2246754A1 - Vecteurs d'apport de structures cochleaires - Google Patents

Vecteurs d'apport de structures cochleaires

Info

Publication number
CA2246754A1
CA2246754A1 CA002246754A CA2246754A CA2246754A1 CA 2246754 A1 CA2246754 A1 CA 2246754A1 CA 002246754 A CA002246754 A CA 002246754A CA 2246754 A CA2246754 A CA 2246754A CA 2246754 A1 CA2246754 A1 CA 2246754A1
Authority
CA
Canada
Prior art keywords
cochleate
delivery vehicles
component
biologically relevant
cochleate delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002246754A
Other languages
English (en)
Other versions
CA2246754C (fr
Inventor
Raphael James Mannino
Susan Gould-Fogerite
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Medicine and Dentistry of New Jersey
Albany Medical College
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/001704 external-priority patent/WO1996025942A1/fr
Application filed by Individual filed Critical Individual
Publication of CA2246754A1 publication Critical patent/CA2246754A1/fr
Application granted granted Critical
Publication of CA2246754C publication Critical patent/CA2246754C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18834—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002246754A 1996-02-22 1997-02-21 Vecteurs d'apport de structures cochleaires Expired - Fee Related CA2246754C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/US96/01704 1996-02-22
PCT/US1996/001704 WO1996025942A1 (fr) 1995-02-22 1996-02-22 Phospholipides cochleaires utilises dans l'administration de medicaments
PCT/US1997/002632 WO1997030725A1 (fr) 1996-02-22 1997-02-21 Vecteurs d'apport de structures cochleaires

Publications (2)

Publication Number Publication Date
CA2246754A1 true CA2246754A1 (fr) 1997-08-28
CA2246754C CA2246754C (fr) 2002-10-22

Family

ID=22254697

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002246754A Expired - Fee Related CA2246754C (fr) 1996-02-22 1997-02-21 Vecteurs d'apport de structures cochleaires

Country Status (2)

Country Link
CA (1) CA2246754C (fr)
WO (1) WO1997030725A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810051D0 (en) * 1998-05-11 1998-07-08 Nycomed Imaging As Contrast media
US6340591B1 (en) 1998-12-14 2002-01-22 University Of Maryland Integrative protein-DNA cochleate formulations and methods for transforming cells
US6153217A (en) 1999-01-22 2000-11-28 Biodelivery Sciences, Inc. Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
AU2007200813B2 (en) * 1999-01-22 2010-06-03 Biodelivery Sicencies, Inc. Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
AU3111401A (en) * 2000-01-24 2001-07-31 Biodelivery Sciences, Inc. New cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
JP4886297B2 (ja) 2002-11-01 2012-02-29 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド ジオデート送達媒体
WO2004064805A1 (fr) * 2003-01-15 2004-08-05 Biodelivery Sciences International, Inc. Preparations cochleaires de nutriants fragiles
EP1624858B1 (fr) 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Nouveaux procédés de formation de structures cochléaires
WO2004091572A2 (fr) * 2003-04-09 2004-10-28 Biodelivery Sciences International, Inc. Compositions contenant des structures cochleaires, dirigees contre l'expression de proteines
EP1674093A4 (fr) * 2003-10-15 2009-12-09 Nanoegg Res Lab Inc Procede de controle de la taille particulaire de nanoparticules d'acide retinoique revetues d'un sel inorganique metallique polyvalent et nanoparticules obtenues par ledit procede
JP4627727B2 (ja) * 2003-10-15 2011-02-09 株式会社ナノエッグ 多価金属無機塩被覆レチノイン酸ナノ粒子含有組成物
US8951563B2 (en) 2009-08-06 2015-02-10 Technion Research & Development Foundation Limited Antibiotic drug delivery and potentiation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5571517A (en) * 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories

Also Published As

Publication number Publication date
CA2246754C (fr) 2002-10-22
WO1997030725A1 (fr) 1997-08-28

Similar Documents

Publication Publication Date Title
CA2212382A1 (fr) Substances cochleaires utilisees comme excipients
CA2246754A1 (fr) Vecteurs d'apport de structures cochleaires
AU570875B1 (en) Multi-system heat pump air-conditioner with single outdoor unit.
GB2225065B (en) Improvements in or relating to pumping devices.
EP0650722A3 (fr) Particules d'invasion enrobées d'une protéine.
CA2180978A1 (fr) Monomeres et oligomeres contenant de la pyrrolidine
EP0631366A3 (fr) Pompe à entraînement magnétique avec un élément de palier de butée arrière.
CA2332915A1 (fr) Compositions renfermant des analogues d'acide gamma-aminobutyrique (gaba) et de la cafeine
EP0827749A3 (fr) Solution pour dialyse péritonéale
IT9048350A0 (it) Complesso di accostamento per cuscinetto di spinta di innesto, in particolare per autoveicolo.
AU5675090A (en) An arrangement in goods vehicles
AU6285390A (en) Improvements in or relating to i.c. engines
HUT52847A (en) Compressor unit with propeller pump or similar device
EP0643447A3 (fr) Embout pour faire frotter des contacts l'un contre l'autre.
CA2180867A1 (fr) Diols monomeres et oligomeres a liaison phosphate formes a partir de ces derniers
EG20946A (en) Polyaspartic acid its analogues in combination with insecticides
IE872589L (en) Treated lipid regulator
AU2916684A (en) Polyamide compositions, use in contact with antifreeze
AU3787797A (en) Drinkable, acid nutrient composition with long shelf life and health-promoting action
AU3362993A (en) Improvements in or relating to pumping systems
AU6293798A (en) Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications
AU636695B2 (en) Display unit, in particular for motor vehicles
McGrath Postsecondary participation in Newfoundland
CA2233751A1 (fr) Tableau d'affichage ameliore et methode pour reduire l'inventaire de tableaux d'affichage
AU3229697A (en) Improved blood contact surfaces using extracellular matrix synthesized (in vitro) having bioactive species immobilized thereto

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130221